Weekly Rundown: Key Catalysts for Small-Cap Stocks (November 3-7)

From recent disclosures to corporate shifts, we’ve highlighted the top small-cap catalysts to watch. Here’s your weekly preview (November 3-7).

--

BIO-Europe 2025: Presenting Companies Announced

Companies are set to present at the 31st Annual BIO-Europe Conference, the leading event for global biopharmaceutical collaboration and innovation. Location: Vienna, Austria, Dates: November 3–5, 2025 BIO-Europe brings together 5,700+ attendees from over 3,000 companies, including top-tier pharmaceutical firms, cutting-edge biotech innovators, and international investors.

Featured Presenting Companies:

OSTX, IMUX, AZTR, TLSA, OKYO, APVO, HOTH, FBLG, EDSA

Spartan Capital Investor Conference 2025: Presenting Companies

Held on November 3, 2025, in New York City, the Spartan Capital Investor Conference will welcome over 50 public and private companies, alongside a network of institutional investors, family offices, and high-net-worth individuals.

This dynamic one-day event features:

● Company presentations

● Main-stage discussions

● Strategically coordinated one-on-one investor meetings These sessions are designed to foster meaningful engagements between growth-stage companies and investors actively seeking new opportunities.

Featured Presenting Companies:

ROLR, LIXT, XHLD, ANIX, RVPH, SOTK

ObesityWeek® 2025: Presenting Companies

ObesityWeek® 2025 will take place November 4–7, 2025, in Atlanta, Georgia, bringing together researchers, clinicians, and advocates from across the full spectrum of obesity science and care. This premier international conference spans everything from cutting-edge basic research to clinical applications and public policy—delivering the latest in evidence-based treatments, prevention strategies, and multidisciplinary approaches to obesity as a chronic disease.

With programming that includes 250+ expert speakers and covers:

● Diet and lifestyle interventions

● Medical and surgical treatments

● Pediatrics to geriatrics

● Health equity and underserved populations ObesityWeek® offers critical insights for anyone working in obesity and metabolic health.

Featured Presenting Companies:

BMEA, VERU, IBIO, MTVA, RANI

ASN Kidney Week 2025: Presenting Companies

The American Society of Nephrology (ASN) will host Kidney Week 2025 from November 5–9, 2025, at the George R. Brown Convention Center in Houston, Texas. As the leading annual event in the field of nephrology, Kidney Week brings together professionals from around the world to explore the latest developments in kidney research, clinical care, and therapeutic innovation.

Attendees can expect in-depth discussions on:

● Cutting-edge research

● Advancements in kidney disease treatment

● Innovations in patient care

Featured Presenting Companies:

UNCY, ELDN, PROK, AKBA, RMTI, CLYM

SITC 2025: 40th Anniversary Annual Meeting – Presenting Companies

The Society for Immunotherapy of Cancer (SITC) will celebrate its 40th Anniversary Annual Meeting and Pre-Conference Programs from November 5–9, 2025, in National Harbor, Maryland, USA. This landmark gathering will bring together global leaders from academia, industry, regulatory bodies, and government agencies to commemorate four decades of progress in cancer immunotherapy.

Focused on improving outcomes for cancer patients, the meeting will feature strategies grounded in both basic and applied immunotherapy. Attendees will include:

● Basic and clinical investigators

● Translational researchers

● Clinicians and allied health professionals

● Graduate students, post-docs, pharmacists, and payers

Featured Presenting Companies:

APVO, XLO, OPK, VRCA, AKTX, HOWL, BCAB, EVAX, CLDI, CNTX, CGEN, BCTX, HCWB

AASLD – The Liver Meeting® 2025: Presenting Companies

The Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)—The Liver Meeting® 2025—will take place November 7–11, 2025, in Washington, D.C.. This premier global event convenes the international hepatology community, including clinicians, researchers, surgeons, trainees, advocates, academics, and policymakers—all united in the mission to advance liver health worldwide.

The program will showcase:

● The latest breakthroughs in liver disease research

● Evidence-based tools to enhance patient care

● Sessions tackling today’s most pressing clinical challenges in hepatology

Attendees will engage with leading experts and explore innovative strategies to address liver disease across diverse populations.

Featured Presenting Companies:

GNFT, MTVA, ALT, GALT, AVIR, ABUS

Other Companies with Material Events This Week:

NNBR: The President and CEO will present at the Gabelli Funds 49th Annual Automotive Symposium on November 3, 2025, in Las Vegas.

CNTB: An investor webinar hosted by RedChip Companies will take place on November 3, 2025, at 4:15 p.m. ET, highlighting developments in the treatment of inflammatory diseases.

LODE: Participating as a Silver Sponsor at the 51st Annual New Orleans Investment Conference (November 2–5, 2025), a company executive will present on November 3, from 3:50 to 4:10 p.m. at Booth 316.

ADCT: A virtual fireside chat is scheduled for November 3, 2025, at 12:00 p.m. ET as part of the Stephens Biotechnology Virtual Fireside Chats series.

AMBP: A quarterly interim dividend of $0.10 per ordinary share was declared, payable on November 13, 2025, to shareholders of record as of November 3, 2025.

PRQR: A virtual Investor and Analyst Event titled "Entering the Clinic with AX-0810" will be held on November 3, 2025, beginning at 10:00 a.m. ET.

TYGO: A three-stop training roadshow in the UK will run from November 3–6, 2025, offering hands-on technical sessions in Glasgow, Rugby, and Bristol.

GLDG: Presentation scheduled at Red Cloud’s Fall Mining Showcase 2025 on November 4–5 at the Sheraton Centre Toronto Hotel.

REFR: Will demonstrate its new SPD-SmartGlass product at GlassBuild America 2025 in Orlando, Florida, from November 4–6 at Booth 9034.

CWD: Sponsoring the 2025 SmartCon Conference in New York City on November 4–5, with executive leadership attending alongside major financial institutions.

INO: Will participate in the Stephens Biotechnology Virtual Fireside Chat on November 4, 2025, from 3:00 to 3:50 p.m. ET, and hold one-on-one investor meetings.

FMST: Set to present at Red Cloud’s Fall Mining Showcase 2025 on November 4–5 in Toronto, highlighting recent developments.

LIDR: Showcasing advanced lidar sensor technology at the Resilient City Expo in Houston, Texas, from November 5–6, 2025, at Booth #RC310.

CODX: Hosting a virtual fireside chat on November 5, 2025, at 11:00 a.m. ET, including updates on a Middle East joint venture.

IMNN: Presenting a trials-in-progress abstract at the 2025 IGCS Annual Global Meeting in Cape Town, South Africa, from November 5–7.

RVPH: Will share negative symptom data from a Phase 3 schizophrenia trial in a poster at the CNS Summit 2025 in Boston, November 2–5.

BNBX: Will speak at SALT London and Digital Commonwealth events on November 5, 2025, covering DeFi and evolving digital asset technologies.

EQ: Hosting a virtual KOL event on November 5, 2025, at 12:00 p.m. ET, with expert discussions on ulcerative colitis and anti-inflammatory therapies.

JAGX: Presenting pediatric gastro trial data at the NASPGHAN Annual Meeting in Chicago, taking place November 5–8, 2025.

NRSN: Positive results from a Phase 2 Alzheimer’s trial will be presented at the CNS Summit 2025 in Boston, November 2–5.

CATX: Participating in one-on-one investor meetings at the Truist Securities BioPharma Symposium on November 6, 2025, in New York City.

OABI: Engaging in one-on-one investor meetings at the same symposium on November 6 at the Lotte New York Palace Hotel.

SNAL: Announced momentum in wishlist growth for Rebel Engine during Steam Next Fest, ahead of its official launch on November 6, 2025.

BRBS: Declared a special cash dividend of $0.25 per share, payable on November 21, 2025, to shareholders of record on November 7, 2025.

ESPR: Will deliver an oral and a poster presentation at the AHA Scientific Sessions in New Orleans, November 7–10, 2025.

MIST: Presenting new data on self-administered etripamil for PSVT during the AHA Scientific Sessions, November 7–10, 2025.

VSTD: Announced that its wholly owned subsidiary, Vestand Korea Company Limited, has entered into a Share Purchase Agreement to acquire 21,000 shares of AI Mindbot Equity Union for approximately $6.4 million USD. Upon closing—expected on or about November 7, 2025—Vestand Korea will become the controlling shareholder, owning over 89% of AI Mindbot. Notably, AI Mindbot is the largest shareholder of Xcure Corp., a Kosdaq-listed company specializing in smart card and mobile security platforms. As part of the agreement, four out of seven directors of Xcure Corp. are expected to be replaced with individuals nominated by Vestand Korea at an extraordinary shareholders’ meeting scheduled for November 7.

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.